Compare ARK Genomic Revolution ETF (ARKG) vs Coinbase Global, Inc. (COIN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Coinbase Global, Inc. — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Coinbase Global, Inc. trades at $157.1 (market cap $41.91B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Coinbase Global, Inc. nearer its low. Which is the better fit depends on your goals.
| ARKG | COIN | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $419.78 |
52-Week Low | $23.09 | $141.09 |
Market Cap | — | $41.91B |
Enterprise Value | — | $39.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
COIN trades at $159.07, up 0.4% on the day, with a bearish technical signal from moving averages despite neutral oscillators. The company reported mixed Q1 2026 earnings, missing estimates, but maintains strong revenue growth and a 73.32% gross margin. Analyst consensus remains bullish with a $230.15 price target, supported by recent regulatory developments like Circle's OCC trust bank approval (Reuters, 2026-07-10).
The outlook is cautiously optimistic given analyst support and improving cash flows, but risks include earnings volatility and regulatory uncertainty. Investment opportunity hinges on execution amid competitive pressures, with the stock offering potential upside if operational trends stabilize.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Coinbase Global, Inc.
Coinbase Global, Inc. is a regulated cryptocurrency company that provides customers around the world with a platform for buying, selling, transferring, and storing digital assets. The Company offers a variety of products and services that enable individuals, businesses, and developers to participate in the cryptoeconomy.
Read more on COIN →
